Infraredx yesterday registered for an initial public offering with the Securities & Exchange Commission, estimating the flotation’s worth at $55 million.
Burlington, Mass.-based Infraredx makes an imaging system that combines intravascular ultrasound and near-infrared spectroscopy to provide images of the interior of coronary blood vessels.
The company says the device is designed to detect lipid-core-containing plaque, which it says is implicated in higher risk for heart attack or stroke.
Help employers find you! Check out all the jobs and post your resume.
